Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital

APMIS

Volumn 118, Issue 10, 2010, Pages 801-808

  Park, Soon Deok ^a   Uh, Young ^a   Lee, Gyusang ^a   Lim, Kwanhun ^a   Kim, Jong Bae ^a   Jeong, Seok Hoon ^b  

^a Yonsei University Wonju   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

AmpC lactamase; boronic acid; Extended spectrum lactamase; polymerase chain reaction; pulsed field gel electrophoresis

Indexed keywords

BETA LACTAMASE AMPC; CEFOXITIN; EXTENDED SPECTRUM BETA LACTAMASE; AMPC BETA-LACTAMASES; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC VARIABILITY; KLEBSIELLA PNEUMONIAE; KOREA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEUS MIRABILIS; PULSED FIELD GEL ELECTROPHORESIS; SALMONELLA; TERTIARY HEALTH CARE; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; EVALUATION STUDY; GENETICS; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PREVALENCE; SOUTH KOREA;

BACTERIAL PROTEINS; BETA-LACTAMASES; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEUS MIRABILIS; REPUBLIC OF KOREA; SALMONELLA;

EID: 77956899999     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02663.x     Document Type: Article

References (30)

1. Beg AZ, Ahmad I. Effect of Plumbago zeylanica and certain curing agents on multidrug resistant bacteria of clinical origin. World J Microbiol Biotechnol 2000 16 : 841 44.
2. Robin EH, Anril WM, Loeto M, Keith K. Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana. Int J Infect Dis 1998 3 : 18 25.
3. Jeong SH, Bae IK, Lee JH, Sohn SG, Kang GH, Jeon GJ, et al. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J Clin Microbiol 2004 42 : 2902 6.
4. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, et al. Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006 12 : 44 9.
5. Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, et al. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diag Microbiol Infect Dis 2006 55 : 219 24.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. Document M100-S16.
7. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005 43 : 4163 7.
8. Brenwald NP, Jevons G, Andrews J, Ang L, Fraise P. Disc methods for detecting AmpC β-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 2005 56 : 600 1.
9. Yagi T, Wachino J, Kurokawa H, Suzuki S, Yamane K, Doi Y, et al. Practical methods using boronic acid compounds for identification of class C β-lactamase producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005 43 : 2551 8.
10. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin B, et al. The inhibition of class C β-lactamases by boronic acids. Biochem J 1983 209 : 229 33.
11. Uh Y, Son JS, Hwang GY, Jang IH, Yoon KJ, Seo DM. Microplate identification system of Enterobacteriacae. Korean J Clin Microbiol 1999 2 : 135 43.
12. Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, et al. Norwegian ESBL Study Group. Effects of phenotype and genotype on methods for detection of extended-spectrum β-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 2007 45 : 199 205.
13. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002 40 : 2153 62.
14. Ananthkrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended-spectrum β-lactamase producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 2000 18 : 160 5.
15. Shahid M, Malik A, Sheeba. Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC β-lactamases isolated from hospitalized burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 2003 228 : 181 6.
16. Rao PS, Shivananda PG. Bacteraemia due to non-fermenting gram-negative bacilli in immunocompromised patients. Indian J Med Microbiol 1993 11 : 95 9.
17. Veenu, Sikka R, Arora DR. Isolation and susceptibility pattern of nonfermenting Gram-negative bacilli from clinical samples. Indian J Med Microbiol 1999 17 : 14 17.
18. Barnaud G, Arlet G, Verdet C, Gaillot O, Lagrange PH, Philippon A. Salmonella enteritidis: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother 1998 42 : 2352 8.
19. Black JA, Thomson KS, Pitout JD. Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases. J Clin Microbiol 2004 42 : 2203 6.
20. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007 57 : 315 8.
21. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989 17 : 316 21.
22. Gaillot O, Clement C, Simonet M, Philippon A. Novel transferable -lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J Antimicrob Chemother 1997 39 : 85 7.
23. Kim JY, Park YJ, Lee SO, Song W, Jeong SH, Yoo YA, et al. Case report: Bacteremia due to Salmonella enterica serotype Montevideo producing plasmid-mediated AmpC β-lactamase (DHA-1). Ann Clin Lab Sci 2004 34 : 214 7.
24. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004 48 : 533 7.
25. Moland ES, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob Agents Chemother 2002 46 : 3837 42.
26. Yan JJ, Ko WC, Wu HM, Tsai SH, Chuang CL, Wu JJ. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 2004 42 : 5337 40.
27. Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, et al. Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC β-lactamase resistance in China. J Clin Microbiol 2008 46 : 1317 21.
28. Muratani T, Kobayashi T, Matsumoto T. Emergence and prevalence of β-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int J Antimicrob Agents 2006 27 : 491 9.
29. Song W, Moland ES, Hanson ND, Lewis JS, Jorgensen JH, Tomson KS. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. J Clin Microbiol 2005 43 : 4891 4.
30. Ahmad M, Urban C, Mariano N, Bradford PA, Calcagni E, Projan SJ, et al. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis 1999 29 : 352 5.